A new, low-cost Texas Children’s Hospital vaccine gets approval for use in India | Houston Public Media
The goal is to make the vaccine available in other underserved nations across the globe to help prevent future variants of concern from forming.
Hasnain says:
Feel good story of the day: I hope this one works out. No patent burden is huge.
“Hotez said because the Corbevax vaccine is cheap, has no patents and uses traditional protein-based vaccine technology it will be easier for other countries to mass-produce and distribute it.
"It's a similar technology used to make the Hepatitis B vaccine that's been made locally and all over the world for three or four decades," he said. "It really does check all of the boxes you would want for a global health vaccine."”